Severe
infections frequently require admission to the intensive care unit and cause life-threatening complications in
critically ill patients. In this setting, severe
infections are acknowledged as prerequisites for the development of
sepsis, whose pathophysiology implies a dysregulated host response to pathogens, leading to disability and mortality worldwide.Vitamin D is a secosteroid
hormone that plays a pivotal role to maintain immune system homeostasis, which is of paramount importance to resolve
infection and modulate the burden of
sepsis. Specifically,
vitamin D deficiency has been widely reported in
critically ill patients and represents a risk factor for the development of severe
infections,
sepsis and worse clinical outcomes. Several studies have demonstrated the feasibility, safety and effectiveness of
vitamin D supplementation strategies to improve
vitamin D body content, but conflictual results support its benefit in general populations of
critically ill patients. In contrast, small randomised clinical trials reported that
vitamin D supplementation may improve host-defence to pathogen invasion via the production of
cathelicidin and specific
cytokines. Nonetheless, no large scale investigations have been designed to specifically assess the impact of
vitamin D supplementation on the outcome of
critically ill septic patients admitted to the intensive care unit.